Wednesday's ETF Highlights: IHI, BITQ
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 22 2025
0mins
Source: NASDAQ.COM
ETF Performance: The Bitwise Crypto Industry Innovators ETF is down approximately 7.4% in Wednesday afternoon trading, underperforming other ETFs.
Weakest Components: Key components contributing to the ETF's decline include Hut 8, which fell by about 16.8%, and Galaxy Digital, which dropped by about 13.8%.
Market Context: The performance of the ETF reflects broader trends in the cryptocurrency market, impacting investor sentiment.
Author's Perspective: The views expressed in the article are those of the author and do not necessarily represent Nasdaq, Inc.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ISRG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ISRG
Wall Street analysts forecast ISRG stock price to rise
20 Analyst Rating
16 Buy
4 Hold
0 Sell
Strong Buy
Current: 402.380
Low
575.00
Averages
637.32
High
740.00
Current: 402.380
Low
575.00
Averages
637.32
High
740.00
About ISRG
Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Intuitive Surgical Extends Instrument Lifetimes Amid Revenue Growth
- Significant Revenue Growth: Intuitive Surgical reported a 23% year-over-year revenue increase in Q1, reaching $2.77 billion, demonstrating strong performance in the medical device market despite stock price pressures.
- Extended Instrument Lifetimes: The company increased the usage count of five force-feedback tools from six to fifteen, aimed at alleviating supply chain bottlenecks, which, while not impacting revenue per procedure, may enhance hospital adoption of these high-demand tools.
- Enhanced Customer Loyalty: By raising the maximum usage of older standard instruments, which may slightly impact instrument and accessory revenue, the company aims to lower hospital costs and strengthen customer loyalty, with this segment generating $1.69 billion in Q1.
- Market Reaction Analysis: While analysts remain cautious about Intuitive's outlook, Goldman Sachs raised its price target to $558, arguing that the market's reaction to the extended instrument lifetimes reflects a misunderstanding, with expectations for stable revenue growth ahead.
See More
Goldman Analyst Optimistic About Intuitive Surgical's Future
- Instrument Lifetime Adjustments: Intuitive Surgical has increased the lifespan of five force-feedback tools from six to fifteen uses, addressing supply chain bottlenecks and facilitating hospital adoption, despite market fears of revenue impact.
- Revenue Growth Performance: In Q1, Intuitive Surgical's overall revenue grew by 23% year-over-year to $2.77 billion, with earnings per share at $2.28, reflecting strong market performance and resilience.
- Market Reaction Analysis: While some investors viewed the extended lifetimes as a defensive move against competitors, Goldman Sachs argues this is a long-term strategy, supported by historical data showing minimal revenue impact and potential for increased customer loyalty.
- Future Watch Points: Intuitive Surgical's systems performed 847,000 procedures in Q1, a 16% year-over-year increase, but the company faces a premium valuation of over 49 times earnings, necessitating clearer communication on 2027 instrument changes in the upcoming earnings report to alleviate market concerns.
See More
Motley Fool Rule Breaker Investing: Transparency and Financial Freedom
- Importance of Transparency: The SEC is considering a proposal to reduce public company reporting from quarterly to semi-annually, raising significant investor concern as many believe that transparency is crucial for long-term investment success, and reducing reporting frequency could lead to information asymmetry that negatively impacts investment decisions.
- Investor Advocacy: Listeners of Motley Fool Rule Breaker Investing are actively engaging with the SEC to express support for maintaining quarterly reports, emphasizing that transparency is not only key to investment success but also vital for maintaining market fairness, and this collective action could influence the SEC's final decision.
- Personal Investment Stories: An anonymous listener shared how adhering to the principles of Motley Fool Investing has led to his financial freedom, describing how he has been able to help others and support family members, showcasing that the returns from investing extend beyond financial gains to embody social responsibility.
- Education and Responsibility: Another listener highlighted the importance of educating his daughters about investment basics, fostering a sense of responsibility and long-term thinking, which underscores the role of education in achieving financial freedom and promotes overall family financial health.
See More
Motley Fool Rule Breaker Investing Mailbag Insights
- Importance of Transparency: The Motley Fool advocates against the SEC's proposal to reduce corporate reporting from quarterly to semi-annually, arguing that this would diminish transparency and increase uncertainty for individual investors, ultimately impacting their decision-making capabilities.
- Investor Success Stories: An anonymous investor shared achievements made by following Foolish principles, including providing memorable experiences for a cancer patient and alleviating financial burdens for children, highlighting the significance of financial freedom and its positive impact on others' lives.
- Investment Habit Sharing: A listener inquired about when to add to winning stocks, and the Motley Fool founder suggested increasing investments when stocks perform well, emphasizing the importance of focusing on winners for long-term gains.
- Education and Financial Freedom: A German police officer discussed how he educates his daughters about investing, instilling a sense of responsibility and long-term thinking, emphasizing that financial security is not just about wealth accumulation but creating opportunities for freedom of choice.
See More
Investment Comparison: Abbott vs. Intuitive Surgical
- Abbott's Diversification Advantage: Abbott operates across four primary segments—medical devices, diagnostics, nutrition, and pharmaceuticals—achieving nearly $44.3 billion in revenue for FY 2025, reflecting a 5.7% year-over-year growth that underscores its stable cash flows and broad customer base across market cycles.
- Intuitive Surgical's Growth Potential: Intuitive Surgical reported approximately $10.1 billion in revenue for FY 2025, marking a significant 20.5% increase, with its robotic surgery platform installed in over 7,500 hospitals globally, indicating strong market demand and high profit margins.
- Financial Health Comparison: Abbott's debt-to-equity ratio stands at about 0.3, indicating a relatively stable financial position, while Intuitive Surgical boasts virtually no debt with a 0.0 ratio and a current ratio of 4.9, showcasing excellent liquidity.
- Risks and Regulatory Challenges: Abbott faces product liability and legal risks, particularly related to its infant formula, while Intuitive Surgical must navigate complex global regulations and cybersecurity threats, factors that could impact the future market performance of both companies.
See More
Intuitive Surgical's Market Leadership Strengthens
- Da Vinci System Innovation: Intuitive Surgical's Da Vinci 5 system installations reached 232 in Q1, a 58% increase from 147 a year earlier, demonstrating strong market momentum for the new product and further solidifying the company's market leadership.
- Strong Competitive Moat: With most surgeons trained on the Da Vinci system, hospitals tend to stick with the platform after purchase, significantly reducing the threat from competitors and ensuring Intuitive Surgical's sustained profitability.
- Diverse Revenue Streams: In the latest quarter, revenue from accessories and instruments totaled $1.6 billion, compared to $650 million from system sales, indicating the company's ability to generate high recurring revenue through accessories and service contracts, enhancing financial stability.
- Global Market Expansion: The installed base of Da Vinci systems grew to 11,395, a 12% year-over-year increase, while global procedures rose by 16%, indicating increased hospital reliance on the platform, thereby driving long-term revenue growth for the company.
See More
Intuitive Surgical Extends Instrument Lifetimes Amid Revenue Growth
- Significant Revenue Growth: Intuitive Surgical reported a 23% year-over-year revenue increase in Q1, reaching $2.77 billion, demonstrating strong performance in the medical device market despite stock price pressures.
- Extended Instrument Lifetimes: The company increased the usage count of five force-feedback tools from six to fifteen, aimed at alleviating supply chain bottlenecks, which, while not impacting revenue per procedure, may enhance hospital adoption of these high-demand tools.
- Enhanced Customer Loyalty: By raising the maximum usage of older standard instruments, which may slightly impact instrument and accessory revenue, the company aims to lower hospital costs and strengthen customer loyalty, with this segment generating $1.69 billion in Q1.
- Market Reaction Analysis: While analysts remain cautious about Intuitive's outlook, Goldman Sachs raised its price target to $558, arguing that the market's reaction to the extended instrument lifetimes reflects a misunderstanding, with expectations for stable revenue growth ahead.
See More
Goldman Analyst Optimistic About Intuitive Surgical's Future
- Instrument Lifetime Adjustments: Intuitive Surgical has increased the lifespan of five force-feedback tools from six to fifteen uses, addressing supply chain bottlenecks and facilitating hospital adoption, despite market fears of revenue impact.
- Revenue Growth Performance: In Q1, Intuitive Surgical's overall revenue grew by 23% year-over-year to $2.77 billion, with earnings per share at $2.28, reflecting strong market performance and resilience.
- Market Reaction Analysis: While some investors viewed the extended lifetimes as a defensive move against competitors, Goldman Sachs argues this is a long-term strategy, supported by historical data showing minimal revenue impact and potential for increased customer loyalty.
- Future Watch Points: Intuitive Surgical's systems performed 847,000 procedures in Q1, a 16% year-over-year increase, but the company faces a premium valuation of over 49 times earnings, necessitating clearer communication on 2027 instrument changes in the upcoming earnings report to alleviate market concerns.
See More
Motley Fool Rule Breaker Investing: Transparency and Financial Freedom
- Importance of Transparency: The SEC is considering a proposal to reduce public company reporting from quarterly to semi-annually, raising significant investor concern as many believe that transparency is crucial for long-term investment success, and reducing reporting frequency could lead to information asymmetry that negatively impacts investment decisions.
- Investor Advocacy: Listeners of Motley Fool Rule Breaker Investing are actively engaging with the SEC to express support for maintaining quarterly reports, emphasizing that transparency is not only key to investment success but also vital for maintaining market fairness, and this collective action could influence the SEC's final decision.
- Personal Investment Stories: An anonymous listener shared how adhering to the principles of Motley Fool Investing has led to his financial freedom, describing how he has been able to help others and support family members, showcasing that the returns from investing extend beyond financial gains to embody social responsibility.
- Education and Responsibility: Another listener highlighted the importance of educating his daughters about investment basics, fostering a sense of responsibility and long-term thinking, which underscores the role of education in achieving financial freedom and promotes overall family financial health.
See More
Motley Fool Rule Breaker Investing Mailbag Insights
- Importance of Transparency: The Motley Fool advocates against the SEC's proposal to reduce corporate reporting from quarterly to semi-annually, arguing that this would diminish transparency and increase uncertainty for individual investors, ultimately impacting their decision-making capabilities.
- Investor Success Stories: An anonymous investor shared achievements made by following Foolish principles, including providing memorable experiences for a cancer patient and alleviating financial burdens for children, highlighting the significance of financial freedom and its positive impact on others' lives.
- Investment Habit Sharing: A listener inquired about when to add to winning stocks, and the Motley Fool founder suggested increasing investments when stocks perform well, emphasizing the importance of focusing on winners for long-term gains.
- Education and Financial Freedom: A German police officer discussed how he educates his daughters about investing, instilling a sense of responsibility and long-term thinking, emphasizing that financial security is not just about wealth accumulation but creating opportunities for freedom of choice.
See More
Investment Comparison: Abbott vs. Intuitive Surgical
- Abbott's Diversification Advantage: Abbott operates across four primary segments—medical devices, diagnostics, nutrition, and pharmaceuticals—achieving nearly $44.3 billion in revenue for FY 2025, reflecting a 5.7% year-over-year growth that underscores its stable cash flows and broad customer base across market cycles.
- Intuitive Surgical's Growth Potential: Intuitive Surgical reported approximately $10.1 billion in revenue for FY 2025, marking a significant 20.5% increase, with its robotic surgery platform installed in over 7,500 hospitals globally, indicating strong market demand and high profit margins.
- Financial Health Comparison: Abbott's debt-to-equity ratio stands at about 0.3, indicating a relatively stable financial position, while Intuitive Surgical boasts virtually no debt with a 0.0 ratio and a current ratio of 4.9, showcasing excellent liquidity.
- Risks and Regulatory Challenges: Abbott faces product liability and legal risks, particularly related to its infant formula, while Intuitive Surgical must navigate complex global regulations and cybersecurity threats, factors that could impact the future market performance of both companies.
See More
Intuitive Surgical's Market Leadership Strengthens
- Da Vinci System Innovation: Intuitive Surgical's Da Vinci 5 system installations reached 232 in Q1, a 58% increase from 147 a year earlier, demonstrating strong market momentum for the new product and further solidifying the company's market leadership.
- Strong Competitive Moat: With most surgeons trained on the Da Vinci system, hospitals tend to stick with the platform after purchase, significantly reducing the threat from competitors and ensuring Intuitive Surgical's sustained profitability.
- Diverse Revenue Streams: In the latest quarter, revenue from accessories and instruments totaled $1.6 billion, compared to $650 million from system sales, indicating the company's ability to generate high recurring revenue through accessories and service contracts, enhancing financial stability.
- Global Market Expansion: The installed base of Da Vinci systems grew to 11,395, a 12% year-over-year increase, while global procedures rose by 16%, indicating increased hospital reliance on the platform, thereby driving long-term revenue growth for the company.
See More
